Overview

Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This is a single-center, multidisciplinary, open-label, single-arm prospective clinical study.
Phase:
Phase 2
Details
Lead Sponsor:
Eye & ENT Hospital of Fudan University
Treatments:
Apatinib
Capecitabine
Cisplatin
Docetaxel